PIK3R2 antibody

Synonyms:MPPH antibody, MPPH1 antibody, P85B antibody, p85 antibody, p85-BETA antibody, PIK3R2 antibody, PI3-kinase regulatory subunit beta antibody, PI3K regulatory subunit beta antibody, PI3-kinase subunit p85-beta antibody, PtdIns-3-kinase regulatory subunit p85-beta antibody
Catalogue No.:FNab10160Reactivity:Human, rat
Host:RabbitTested Application:ELISA, WB
Clonality:polyclonalIsotype:IgG
  • SPECIFICATIONS
Product Name
PIK3R2 antibody
Catalogue No.
FNab10160
Size
100μg
Form
liquid
Purification
Immunogen affinity purified
Purity
≥95% as determined by SDS-PAGE
Clonality
polyclonal
Isotype
IgG
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
Immunogen
Immunogen
Phosphatidylinositol 3-kinase regulatory subunit beta
Alternative Names
MPPH antibody, MPPH1 antibody, P85B antibody, p85 antibody, p85-BETA antibody, PIK3R2 antibody, PI3-kinase regulatory subunit beta antibody, PI3K regulatory subunit beta antibody, PI3-kinase subunit p85-beta antibody, PtdIns-3-kinase regulatory subunit p85-beta antibody
UniProt ID
O00459
Observed MW
81 kDa, 100 kDa
Application
Tested Applications
ELISA, WB
Recommended dilution
WB: 1:500-1:2000
Validated Images
Hela cells were subjected to SDS PAGE followed by western blot with FNab10160(PIK3R2 antibody) at dilution of 1:1000
Background
Phosphatidylinositol 3-kinase (PI3K) plays an important role in the metabolic actions of insulin and is required for adipogenesis. The PI3K pathway has also been identified as an important player in cancer development and progression. The Class IA PI3K heterodimer, which is composed of a P110 catalytic subunit and a P85 regulatory subunit, is activated upon association of the P85 subunit with upstream adaptor proteins or receptor tyrosine kinases. Mutations in PIK3R1 are implicated in cases of breast cancer and associated to SHORT syndrome.